FAK anticorps (pTyr861)
Aperçu rapide pour FAK anticorps (pTyr861) (ABIN361988)
Antigène
Voir toutes FAK (PTK2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pTyr861
-
Specificité
- The antibody detects endogenous level of FAK only when phosphorylated at tyrosine 861.
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific phosphopeptide. The antibody against non-phosphopeptide was removedby chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
-
Immunogène
- Peptide sequence around phosphorylation site of pTyr861 (H-I-Y (p) -Q-P) derived from Human FAK. Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Western blotting: 1:500-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
-
: "Targeting lysophosphatidic acid signaling retards culture-associated senescence of human marrow stromal cells." dans: PLoS ONE, Vol. 7, Issue 2, pp. e32185, (2012) (PubMed).
: "Abnormal cleavage of APP impairs its functions in cell adhesion and migration." dans: Neuroscience letters, Vol. 450, Issue 3, pp. 327-31, (2009) (PubMed).
: "Surface characterization and cytocompatibility of three chitosan/polycation composite membranes for guided bone regeneration." dans: Journal of biomaterials applications, Vol. 24, Issue 3, pp. 209-29, (2009) (PubMed).
: "Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells." dans: European journal of pharmacology, Vol. 602, Issue 1, pp. 124-31, (2008) (PubMed).
-
-
- FAK (PTK2) (PTK2 Protein tyrosine Kinase 2 (PTK2))
-
Autre désignation
- FAK
-
Sujet
- Non-receptor protein-tyrosine kinase implicated in signaling pathways involved in cell motility, proliferation and apoptosis. Activated by tyrosine-phosphorylation in response to either integrin clustering induced by cell adhesion or antibody cross-linking, or via G-protein coupled receptor (GPCR) occupancy by ligands such as bombesin or lysophosphatidic acid, or via LDL receptor occupancy. Plays a potential role in oncogenic transformations resulting in increased kinase activity.
-
Poids moléculaire
- 125 kDa
-
UniProt
- Q05397
-
Pathways
- Response to Growth Hormone Stimulus, CXCR4-mediated Signaling Events, Smooth Muscle Cell Migration, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
Antigène
-